Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.

Yoshikawa, Takumi;Otsuka, Mitsuo;Chiba, Hirofumi;Ikeda, Kimiyuki;Mori, Yuki;Umeda, Yasuaki;Nishikiori, Hirotaka;Kuronuma, Koji;Takahashi, Hiroki;
BMC pulmonary medicine 2020 Vol. 20 pp. 131
266
yoshikawa2020correctionbmc

Abstract

Following publication of the original article [1], the authors have flagged that there is an error in Fig. 3.

Keywords

Breast cancer gene expression prolactin progesterone receptor

Access

DOI:
10.1186/s12890-020-1118-x

Citation

ID: 106952
Ref Key: yoshikawa2020correctionbmc
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
106952
Unique Identifier:
10.1186/s12890-020-1118-x
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store